IMMY

We're Hiring! Join the passionate team at IMMY and help us make a real impact on global health! We’re excited to announce two open roles in our Marketing department: 💼Digital Marketing Specialist 💼 Marketing Assistant At IMMY, we’re more than just a diagnostic company. Every product we ship tells a story—a story of healthier lives, families, and communities. With a culture rooted in Collaboration, Humility, and Drive, we thrive together while making a difference every day. ✨ Why You’ll Love IMMY: ✅ Competitive health plans ✅ Gym reimbursement & paid time off ✅ Family-focused benefits, including maternity and parental leave ✅ 401K plan & tuition reimbursement ✅ Fun perks like holiday celebrations, monthly educational breakfasts, and more! ✅ Casual dress code and IMMY-branded gear 📍 Ready to build a career that matters? Apply today and let’s create healthier lives together! 👉 Visit https://hubs.ly/Q032W07F0 to learn more about these exciting opportunities! #IMMY #MarketingJobs #JoinOurTeam #HealthyLives

Speed matters in fungal diagnostics. 🕒 IMMY’s Histoplasma GM EIA delivers rapid, in-house results in just 2 hours, 15 minutes, reducing misdiagnoses and cutting costs compared to send-out testing. ✔ Sensitivity: 98% ✔ Specificity: 97% ✔ FDA registered for urine samples Discover the power of precision. Learn more: https://hubs.ly/Q032v3N10 #FungalDiagnostics #ThinkFungus #TestFungus #Histoplasmaosis

🔬👨⚕️ "It was definitely a game changer for the lab." – Dr. Carlos Espinoza Vasquez Discover why this clinical microbiologist trusts IMMY's CrAg LFA to deliver life-saving diagnostics. With its user-friendly format and semi-quantitative method, IMMY’s solutions empower labs to provide accurate, high-performance results for Cryptococcus antigen detection. ✨Explore the impact IMMY diagnostics can have in your lab. Learn more: https://hubs.ly/Q032k2HZ0 #FungalDiagnostics #CrAgLFA #ThinkFungus #TestFungus #HealthcareInnovation #LabSolutions

This week in our #FungalEducationFridays series, we want to devote special attention to the impact of climate change on global fungal disease. 📖 Today's post provides a brief summary of a new publication, Climate Change and Medical Mycology, authored by Sarah Sedik, MS, Matthias Egger, MD, and Martin Hoenigl, MD, FECMM, FIDSA, and published in Infectious Disease Clinics of North America. The paper explores how rising temperatures, shifting precipitation patterns, and natural disasters are driving the emergence of new fungal pathogens, altering disease patterns, and exacerbating health disparities worldwide. Find the full article here: https://hubs.ly/Q031-Vhz0 IMMY is especially mindful of this issue as devastating wildfires in Los Angeles highlight the far-reaching impacts of climate change. Beyond the immediate destruction, such disasters contribute to fungal spore dispersal, increasing the risk of infections like coccidioidomycosis (Valley fever) in nearby communities. 🌍 Climate change is fundamentally reshaping the landscape of fungal diseases, creating unprecedented challenges for global health. Rising global temperatures are enabling fungi to adapt to warmer climates, leading to the emergence of thermotolerant pathogens like Candida auris and Cryptococcus deuterogattii. Geographic ranges of diseases such as Valley fever, histoplasmosis, and blastomycosis are expanding, while extreme weather events like hurricanes, floods, and wildfires exacerbate fungal exposure risks. Compounding these challenges, antifungal resistance is rising due to intensified agricultural fungicide use, complicating treatment options. Vulnerable populations, particularly in low-resource settings, face the greatest risks as climate change amplifies health disparities. ⌚At IMMY, we recognize the urgency of these challenges. Early diagnosis and surveillance are critical to combating fungal diseases in a warming world. By providing affordable, accurate diagnostic solutions, we empower healthcare providers to detect infections early, improve patient outcomes, and reduce disease spread. The fight against fungal diseases in a changing climate is a global challenge, but through collaboration, innovation, and dedication, we can make a difference. Together, we can protect communities, save lives, and build a healthier future. #ClimateChange #FungalDiagnostics #GlobalHealth #EarlyDetection #IMMYDiagnostics #ThinkFungus #TestFungus

🌟 Hello, 2025! 🌟 As we kick off the new year, we’re reflecting on an incredible 2024 filled with global travels to academic conferences and tradeshows. Connecting with researchers, clinicians, laboratorians, and hospital administrators worldwide has been a privilege, and we’re inspired by the shared commitment to reducing the burden and mortality of fungal diseases. This year, we’re energized and ready to build on that momentum! With exciting plans for 2025 and new team members eager to hit the ground running, we’re looking forward to expanding IMMY’s reach, forging new connections, and continuing to learn and grow at every event. Which conferences are you most excited about this year? Let us know in the comments! If you’d like to collaborate or connect with IMMY at an upcoming event, reach out to us at marketing@immy.com—we’d love to hear from you! 📩 Here’s to another year of advancing fungal diagnostics and making a meaningful impact in patients’ lives. Let’s get started! #FungalDiagnostics #ThinkFungus #TestFungus #IMMY2025 JT Harrison, Kevin Kurimsky, John Bannister, Gemma Johnson, Diego Hernando Caceres Contreras, Keegan Nees, Matheus Falceta, Meredith Brown, MPH, CPH, Trey Niblett, Chris Bryant, Robyn Crow, Phaninder koppula, Shadrack Were., Brian Doherty

IMMY is excited to share a new study co-authored by our Latin American representative, Diego Caceres, published in Medical Mycology. The study, titled "Evaluation of a commercial Histoplasma antigen detection enzyme immunoassay for the follow-up of histoplasmosis treatment in people living with HIV from Argentina," highlights the value of antigen detection assays in improving outcomes for HIV patients with histoplasmosis. This research evaluated the Histoplasma Galactomannan (GM) EIA kit for monitoring treatment response in 27 patients over 24 weeks. Results showed a significant correlation between decreasing antigen levels and clinical improvement, supporting the kit's potential as a reliable tool for treatment monitoring. Access the full paper here: https://hubs.ly/Q031807_0. Learn more about IMMY's Histoplasma antigen detection enzyme immunoassay: https://hubs.ly/Q03180Jr0. Authors: Fernando Antonio Messina, Emmanuel Marin, Diego Hernando Caceres Contreras, Mercedes Romero, Mariela Manrique, Gabriela Santiso

🎉 Fungal Education Fridays is Back in 2025! 🎉 We're kicking off the new year with a focus on rapid diagnostics for invasive fungal infections (IFIs). These tools are transforming the fight against fungal diseases, which affect over 150M people worldwide. Why Rapid Diagnostics Matter: 🔬 IFIs have high mortality rates ( some as high as >50%), yet early, accurate diagnostics can save up to 80% of patients. 🧪 Traditional culture methods are slow and limited, but IMMY's advanced solutions provide fast, reliable results for better patient outcomes. Key Rapid Diagnostic Solutions: ✅ PCR Kits like AurisID® and CandID® enable precise detection of fungal pathogens, including drug-resistant strains. ✅ Lateral Flow Assays (LFAs) like CrAg and Coccidioides Ab ensure accurate, accessible testing in minutes. ✅ Beta-D-Glucan Testing offers quick, on-site results, enhancing patient management and reducing unnecessary antifungal use. IMMY's mission is clear: to be the world’s leading provider of fungal diagnostics. We’re proud to develop solutions that improve health and save lives. 🔗Ready to learn more about our comprehensive diagnostic portfolio? Contact us today: https://hubs.ly/Q0317M8F0 #FungalEducationFridays #ThinkFungus #TestFungus #RapidDiagnostics #FungalInfection

Today's topic for #FungalEducationFriday: Fungal Diseases in Animals: A Multifaceted Challenge 🐾 Fungal infections pose serious threats to animals, ranging from domestic pets to wildlife. While less common than bacterial or viral infections, fungal diseases can be equally dangerous, impacting animal health and ecosystems. Common Fungal Diseases in Animals 1️⃣ Aspergillosis Caused by Aspergillus fumigatus, this disease affects species as diverse as dogs, cats, birds, and horses. Birds are especially vulnerable due to unique respiratory systems, making aspergillosis a major concern in zoos and wild populations. 2️⃣ Candidiasis Candida albicans is an opportunistic pathogen causing localized or systemic infections in birds, cattle, and other animals, often linked to stress or medical interventions. 3️⃣ Coccidioidomycosis Also known as Valley Fever, this disease is caused by Coccidioides spp. and affects humans and animals alike, particularly dogs. Accurate diagnosis in dogs not only improves their quality of life but also enhances mapping of endemic regions. IMMY's Coccidioides Ab Lateral Flow Assay (LFA) has been validated in canine studies as a rapid, accessible diagnostic tool. A comparative study by Diego Hernando Caceres Contreras and Mark Lindsley highlighted the LFA’s utility: ➡️Accuracy: 82% ➡️Rapid results with minimal lab infrastructure, making it an ideal screening tool. Learn More 📖Read the full study comparing immunodiagnostic assays for canine coccidioidomycosis: https://hubs.ly/Q030gFCy0 IMMY is committed to advancing veterinary diagnostics to combat fungal diseases and support timely, life-saving care. Discover IMMY's solutions: https://hubs.ly/Q030gDbB0 #FungalEducationFridays #FungalDiagnostics #AnimalHealth #Coccidioidomycosis #ThinkFungus #TestFungus #VeterinaryDiagnostics

🌍👩⚕️ "IMMY’s diagnostics, including tests for histoplasmosis, cryptococcosis, and coccidioidomycosis, have enabled early and rapid diagnosis. This has provided patients with timely treatment, directly impacting their survival.” – Dr. Lisandra Serra Damasceno, Infectious Diseases Specialist, Federal University of Ceará and São José Hospital. At IMMY, we are committed to improving health outcomes worldwide through innovative fungal diagnostics. Thank you, Dr. Damasceno, for sharing how IMMY is making a difference in patient care. 💙 Discover our solutions: https://hubs.ly/Q030gNc_0 #FungalDiagnostics #InfectiousDiseases #SavingLives #IMMYDiagnostics #Mycology #Histoplasmosis #Cryptococcosis #Coccidioidomycosis #ThinkFungus

🔬 Tackling AMR & Infectious Diseases: Expert Insights 🌍 The growing threats of antimicrobial resistance (AMR) and infectious diseases demand global action. The Guardian’s AMR & Infectious Diseases special issue brings together expert voices addressing these critical challenges. Explore an insightful interview with Dr. Tom Chiller MD MPHTM from the Centers for Disease Control and Prevention, where he highlights how rapid fungal diagnostics save lives by enabling faster, accurate treatment and combating antifungal resistance. 🔗 Learn more here: https://hubs.ly/Q02_PWbM0 #AntifungalResistance #DiagnosticsMatter #GlobalHealth #OneHealth #IMMY #AMR